Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,738 total articles
George Djurasovic, serving as the Interim General Counsel for Principal Financial Group Inc. (NASDAQ: PFG), has completed two transactions involving the sale of company common stock. The total value of these disposals reached approximately $259,332 during late April 2026. These sales occur against a backdrop of recent positive financial reporting a…
Richard N. Nottenburg, a member of the Board of Directors at Applied Digital Corp. (NASDAQ: APLD), has completed the sale of 25,000 shares of common stock. The transactions, which represent a total value of $832,375, were disclosed in a recent Form 4 filing with the Securities and Exchange Commission. The sales took place over two days at the end o…
Joey B. Hogan, a director for Covenant Logistics Group, Inc. (NASDAQ:CVLG), recently completed a sale of company stock totaling roughly $510,927. The transaction, which took place on April 28, 2026, involved the disposal of 14,700 shares of Class A Common Stock. This movement comes at a time when the company's stock is trading near its 52-week peak…
Peter Rahmer, the Chief Corporate Development Officer at Relay Therapeutics, Inc. (NASDAQ: RLAY), has completed a sale of company common stock. The transaction occurred on April 28, 2026, involving the disposal of 753 shares at a price point of $14.79 per share. This movement resulted in total proceeds of $11,136.The sale was not a discretionary ma…
George K. Ng, serving as both the Chief Executive Officer and a Director of Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), has completed a purchase of common stock in the company. The transaction, which took place on March 31, 2026, involved the acquisition of 2,136 shares at a price point of $2.535 per share, representing a total investment value …
David L. Finkelstein, serving as CEO and Co-CIO of Annaly Capital Management Inc., has completed a sale of 50,000 shares of common stock. The transaction, valued at approximately $1,144,000, occurred on April 27, 2026. This divestment was executed through a Rule 10b5-1 trading plan established on May 16, 2024, specifically intended for estate and t…
Caroline Alting, who serves as the Senior Vice President of Operations Excellence & Sustainability at Noble Corp plc (NYSE: NE), has completed a sale of her company stock. The transaction involved 15,340 A Ordinary Shares, executed on April 28, 2026. This move comes during a period of significant price appreciation for Noble Corp, as the stock rece…
Owlet, Inc. (NASDAQ: OWLT) Chief Financial Officer Amanda Crawford has reported a series of stock sales totaling $112,794. The transactions, which involved the sale of 11,705 shares, occurred at varying price points ranging from $3.20 to $11.50 per share. These disposals were non-discretionary in nature, executed through automatic processes designe…
Martin Roper, the Chief Executive Officer of Vita Coco Company, Inc. (NASDAQ:COCO), has completed a series of stock transactions totaling approximately $2.5 million. The sales occurred over a two-day period in late April 2026, involving 45,544 shares of common stock. These disposals took place against a backdrop of intense upward momentum for the c…
Exzeo Group, Inc. (NASDAQ: XZO) has seen notable insider activity following a recent filing with the Securities and Exchange Commission. Chief Executive Officer Paresh Patel executed a direct purchase of common stock, adding to his existing holdings. This transaction occurs against a backdrop of recent share price volatility, as the company's stock…
Thomas Catinazzo, the Chief Financial Officer of Relay Therapeutics, Inc. (NASDAQ: RLAY), has completed a sale of company common stock. The transaction, valued at $14,375, occurred on April 28, 2026. The shares were sold at a price point of $14.79 per share, which represents a premium compared to the current trading level of $12.96.The sale involve…
Andrew Callos, the Executive Vice President and Chief Commercial Officer of Cytokinetics Inc (NASDAQ:CYTK), has completed a transaction involving the sale of company stock. The sale occurred on April 30, 2026, immediately following the exercise of non-qualified stock options. This activity takes place amid a period of significant clinical focus for…
Joseph S. Galli, a member of the Board of Directors at BV Financial, Inc. (NASDAQ: BVFL), has completed a sale of common stock held through an individual retirement account (IRA). The transaction, which occurred on April 28, 2026, involved the disposal of 5,992 shares for a total consideration of $120,751. This movement comes as the company's stock…
Ruth T. Dowling, who serves as the Executive Vice President, Chief Administrative Officer, General Counsel, and Secretary for American Tower Corp (NYSE: AMT), has completed two transactions involving the sale of company common stock. The total value of the shares sold reached $173,091. These transactions took place in late April 2026, occurring at …
Opaleye Management Inc., a major stakeholder holding a ten percent ownership position in SANUWAVE Health, Inc. (NASDAQ: SNWV), has completed a series of stock sales totaling approximately $1.27 million. The transactions, which were carried out over two consecutive days on April 28 and April 29, 2026, took place amidst a period of notable price vola…
Visa Inc. (NYSE:V) Chief Executive Officer Ryan McInerney has completed a significant sale of company stock. On April 29, 2026, McInerney sold 31,455 shares of Visa’s Class A Common Stock for an aggregate value of $10,699,204. The transaction was conducted through a Rule 10b5-1 trading plan that had been put in place on May 15, 2025.This divestment…
James O. Donnelly, the President and Chief Executive Officer of Norwood Financial Corp. (NASDAQ: NWFL), has expanded his indirect position in the company through a recent stock purchase. On April 29, 2026, Donnelly acquired 100 shares of common stock at a price of $29.06 per share, representing a total transaction value of $2,906. This specific acq…
Cormorant Asset Management, LP, alongside its affiliate Cormorant Global Healthcare Master Fund, LP and Bihua Chen, executed a significant sale of common stock in Bright Minds Biosciences Inc. (NASDAQ: DRUG). The transaction, which took place on April 28, 2026, involved the disposal of 109,331 shares at an average price of $89.5 per share. This liq…
A recent regulatory filing with the Securities and Exchange Commission has revealed that Michelle R. Cassabaum, a director at Ames National Corp (NASDAQ: ATLO), has increased her position in the company through a purchase of common stock. The transaction, which occurred on April 30, 2026, involved the acquisition of 84 shares at a price point of $2…
Jonathan Anderman, the General Counsel for Compass Therapeutics, Inc. (NASDAQ:CMPX), has expanded his holdings in the company through a direct purchase of common stock. The transaction, which took place on April 29, 2026, involved an acquisition of 25,000 shares via the open market at a price per share of $1.89. This move brings the total value of …
Bradley J. Peterson, who serves as the Executive Vice President and Chief Information Officer at NASDAQ, INC. (NASDAQ:NDAQ), has completed a sale of company shares. The transaction, which took place on April 28, 2026, involved the disposal of 7,710 shares of common stock at a price point of $90.82 per share. This sale resulted in total proceeds of …
Neil Lerner, the Chief Accounting Officer of Compass Therapeutics, Inc. (NASDAQ: CMPX), has completed an open market purchase of company stock. The transaction, which was corrected via an amended Form 4 filing to accurately reflect the nature of the trade as an open market acquisition, occurred on April 29, 2026. This insider activity comes during …
Vito S. Pantilione, serving as President and Chief Executive Officer of Parke Bancorp, Inc. (NASDAQ: PKBK), has executed a notable purchase of company common stock. On April 28, 2026, the executive acquired 1,300 shares at a price of $30.3738 per share, representing a total investment of $39,485. This transaction occurred as the stock was trading n…
A recent regulatory filing reveals that Patrick E. Bowe, a director at Andersons, Inc. (NASDAQ: ANDE), has reduced his position in the company through a common stock sale. The transaction took place on April 29, 2026, involving 900 shares sold at a price of $78.06 per share. This divestment resulted in total proceeds of $70,254. Following this spec…
Joseph R. Robinson, a member of the board of directors at WesBanco, Inc. (NASDAQ: WSBC), has increased his position in the company through recent share acquisitions. According to an amended Form 4 filing submitted to the SEC, Mr. Robinson purchased a total of 1,000 shares on April 27, 2026. This transaction, which totaled $34,512, was executed via …
